Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Donehower

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Virology|November 10, 1995
Analysis of human immunodeficiency virus type 1 integrase mutantsM A Ansari-Lari, L A Donehower, R A Gibbs
Virology|August 1, 1995
Analysis of human immunodeficiency virus type 1 integrase mutantsM A Ansari-Lari, L A Donehower, R A Gibbs
Cell|September 10, 1993
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumorsC J Kemp, L A Donehower, A Bradley, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 13, 1999
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer modelJ M Jones, X S Cui, D Medina, et al.
Journal of Internal Medicine|September 1, 1995
Transgenic mouse models for tumour-suppressor genesT R Kumar, L A Donehower, A Bradley, et al.
Nature|November 9, 1995
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53S N Jones, A E Roe, L A Donehower, et al.
Toxicologic Pathology|February 24, 2001
Cancer prevention studies in p53-deficient miceS D Hursting, S N Perkins, L A Donehower, et al.
Oncogene|July 6, 1995
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic miceA Elson, C Deng, J Campos-Torres, et al.
Molecular and Cellular Biology|August 1, 1995
Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomasA M Yahanda, J M Bruner, L A Donehower, et al.
Cancer Research|October 1, 1996
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alphaD A Greenhalgh, X J Wang, L A Donehower, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Virology|November 10, 1995
Analysis of human immunodeficiency virus type 1 integrase mutantsM A Ansari-Lari, L A Donehower, R A Gibbs
Virology|August 1, 1995
Analysis of human immunodeficiency virus type 1 integrase mutantsM A Ansari-Lari, L A Donehower, R A Gibbs
Cell|September 10, 1993
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumorsC J Kemp, L A Donehower, A Bradley, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 13, 1999
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer modelJ M Jones, X S Cui, D Medina, et al.
Journal of Internal Medicine|September 1, 1995
Transgenic mouse models for tumour-suppressor genesT R Kumar, L A Donehower, A Bradley, et al.
Nature|November 9, 1995
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53S N Jones, A E Roe, L A Donehower, et al.
Toxicologic Pathology|February 24, 2001
Cancer prevention studies in p53-deficient miceS D Hursting, S N Perkins, L A Donehower, et al.
Oncogene|July 6, 1995
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic miceA Elson, C Deng, J Campos-Torres, et al.
Molecular and Cellular Biology|August 1, 1995
Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomasA M Yahanda, J M Bruner, L A Donehower, et al.
Cancer Research|October 1, 1996
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alphaD A Greenhalgh, X J Wang, L A Donehower, et al.
Pageof 9